'Alzheimer-like' pathology in a murine model of arterial hypertension

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 939-944

  Carnevale, Daniela ^a   Lembo, Giuseppe ^b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease (AD); Amyloid peptide (A ); Arterial hypertension; Lipopolysaccharide; Murine model

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; ANGIOTENSIN II; APOLIPOPROTEIN E; GLUCOSE TRANSPORTER 1; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; AORTA COARCTATION; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONFERENCE PAPER; DOWN REGULATION; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; FAMILIAL ALZHEIMER DISEASE; FAMILIAL DISEASE; HYPERTENSION; NEUROPATHOLOGY; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; SPORADIC ALZHEIMER DISEASE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN INJURY, CHRONIC; DISEASE MODELS, ANIMAL; ENCEPHALITIS; HUMANS; HYPERTENSION; MICE;

MURINAE;

EID: 79960883495     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390939     Document Type: Conference Paper

References (45)

1. Zlokovic, B.V. (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201
2. De la Torre, J.C. (2003) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33, 1152-1162
3. Fotuhi, M., Hachinski, V. and Whitehouse, P.J. (2009) Changing perspectives regarding late-life dementia. Nat. Rev. Neurol. 5, 649-658
4. Skoog, I. and Gustafson, D. (2006) Update on hypertension and Alzheimer's disease. Neurol. Res. 28, 605-611
5. Hainsworth, A.H. and Markus, H.S. (2008) Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J. Cereb. Blood Flow Metab. 28, 1877-1891
6. Iadecola, C. and Davisson, R.L. (2008) Hypertension and cerebrovascular dysfunction. Cell Metab. 7, 476-484 (Pubitemid 351729202)
7. Tsukuda, K., Mogi, M., Iwanami, J., Min, L.J., Sakata, A., Jing, F., Iwai, M. and Horiuchi, M. (2009) Cognitive deficit in amyloid-β-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-γ activation. Hypertension 54, 782-787
8. Wang, J., Ho, L., Chen, L., Zhao, Z., Zhao, W., Qian, X., Humala, N., Seror, I., Bartholomew, S., Rosendorff, C. and Pasinetti, G.M. (2007) Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J. Clin. Invest. 117, 3393-3402
9. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (Pubitemid 34790756)
10. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W. et al. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870
11. Sterniczuk, R., Dyck, R.H., Laferla, F.M. and Antle, M.C. (2010) Characterization of the 3xTg-AD mouse model of Alzheimer's disease. Part 1. Circadian changes. Brain Res. 1348, 139-148
12. Sterniczuk, R., Antle, M.C., Laferla, F.M. and Dyck, R.H. (2010) Characterization of the 3xTg-AD mouse model of Alzheimer's disease. Part 2. Behavioral and cognitive changes. Brain Res. 1348, 149-155
13. Selkoe, D.J. (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106-113
14. Haass, C. and Selkoe, D.J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112
15. Gianni, D., Li, A., Tesco, G., McKay, K.M., Moore, J., Raygor, K., Rota, M., Gwathmey, J.K., Dec, G.W., Aretz, T. et al. (2010) Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy. Circulation 121, 1216-1226
16. Mackic, J.B., Weiss, M.H., Miao, W., Kirkman, E., Ghiso, J., Calero, M., Bading, J., Frangione, B. and Zlokovic, B.V. (1998) Cerebrovascular accumulation and increased blood - brain barrier permeability to circulating Alzheimer's amyloid β peptide in aged squirrel monkey with cerebral amyloid angiopathy. J. Neurochem. 70, 210-215 (Pubitemid 28020845)
17. 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499
18. Zlokovic, B.V., Ghiso, J., Mackic, J.B., McComb, J.G., Weiss, M.H. and Frangione, B. (1993) Blood-brain barrier transport of circulating Alzheimer's amyloid β. Biochem. Biophys. Res. Commun. 197, 1034-1040
19. Blanc, E.M., Toborek, M., Mark, R.J., Hennig, B. and Mattson, M.P. (1997) Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68, 1870-1881 (Pubitemid 27176122)
20. Thomas, T., Thomas, G., McLendon, C., Sutton, T. and Mullan, M. (1996) β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168-171
21. Davis-Salinas, J., Saporito-Irwin, S.M., Cotman, C.W. and Van Nostrand, W.E. (1995) Amyloid βprotein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65, 931-934
22. Verbeek, M.M., de Waal, R.M., Schipper, J.J. and Van Nostrand, W.E. (1997) Rapid degeneration of cultured human brain pericytes by amyloid β protein. J. Neurochem. 68, 1135-1141
23. Natté, R., de Boer, W.I., Maat-Schieman, M.L., Baelde, H.J., Vinters, H.V., Roos, R.A. and van Duinen, S.G. (1999) Amyloid β precursor protein-mRNA is expressed throughout cerebral vessel walls. Brain Res. 828, 179-183 (Pubitemid 29236490)
24. Fryer, J.D., Taylor, J.W., DeMattos, R.B., Bales, K.R., Paul, S.M., Parsadanian, M. and Holtzman, D.M. (2003) Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. J. Neurosci. 23, 7889-7896 (Pubitemid 37052357)
25. Nicoll, J.A., Yamada, M., Frackowiak, J., Mazur-Kolecka, B. and Weller, R.O. (2004) Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease; Pro-CAA position statement. Neurobiol. Aging 25, 589-597
26. Poulet, R., Gentile, M.T., Vecchione, C., Distaso, M., Aretini, A., Fratta, L., Russo, G., Echart, C., Maffei, A., De Simoni, M.G. and Lembo, G. (2006) Acute hypertension induces oxidative stress in brain tissues. J. Cereb. Blood Flow Metab. 26, 253-262
27. Serrano, F. and Klann, E. (2004) Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res. Rev. 3, 431-443
28. Scharf, M.T., Woo, N.H., Lattal, K.M., Young, J.Z., Nguyen, P.V. and Abel, T. (2002) Protein synthesis is required for the enhancement of long-term potentiation and long-term memory by spaced training. J. Neurophysiol. 87, 2770-2777 (Pubitemid 34670656)
29. Gentile, M.T., Poulet, R., Di Pardo, A., Cifelli, G., Maffei, A., Vecchione, C., Passarelli, F., Landolfi, A., Carullo, P. and Lembo, G. (2009) β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension. Neurobiol. Aging 30, 222-228
30. Carnevale, D., Mascio, G., Ajmone-Cat, M.A., D'Andrea, I., Cifelli, G., Madonna, M., Cocozza, G., Frati, A., Carullo, P., Carnevale, L. et al. (2010) Role of neuroinflammation in hypertension-induced brain amyloid pathology. Neurobiol. Aging, doi:10.1016/j.neurobiolaging.2010.08.013
31. Bailey, T.L., Rivara, C.B., Rocher, A.B. and Hof, P.R. (2004) The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol. Res. 26, 573-578
32. Wu, Z., Guo, H., Chow, N., Sallstrom, J., Bell, R.D., Deane, R., Brooks, A.I., Kanagala, S., Rubio, A., Sagare, A. et al. (2005) Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat. Med. 11, 959-965
33. Mrak, R.E. and Griffin, W.S. (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26, 349-354 (Pubitemid 40082718)
34. Wyss-Coray, T. (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 1005-1015
35. Li, J.J. and Chen, J.L. (2005) Inflammation may be a bridge connecting hypertension and atherosclerosis. Med. Hypotheses 64, 925-929
36. Minghetti, L. (2005) Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 18, 315-321
37. Mrak, R.E. and Griffin, W.S. (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26, 349-354 (Pubitemid 40082718)
38. Nimmerjahn, A., Kirchhoff, F. and Helmchen, F. (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318 (Pubitemid 40746128)
39. Hanisch, U.K. and Kettenmann, H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394
40. Colton, C.A., Mott, R.T., Sharpe, H., Xu, Q., Van Nostrand, W.E. and Vitek, M.P. (2006) Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation 3, 27
41. Mantovani, A., Sica, A., Sozzani, S, Allavena, P., Vecchi, A. and Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686 (Pubitemid 39457982)
42. McGeer, P.L. and McGeer, E.G. (2007) NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 28, 639-647 (Pubitemid 46349357)
43. Yong, V.W. and Rivest, S. (2009) Taking advance of the systemic immune system to cure brain disease. Neuron 64, 55-60
44. Hoozemans, J.J. and O'Banion, M.K. (2005) The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs. Curr. Drug Targets CNS Neurol. Disord. 4, 307-315
45. Perry, V.H., Cunningham, C. and Holmes, C. (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7, 161-167